Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Masao KUWABARA"'
Autor:
Aya Sugiyama, Toshiro Takafuta, Tomoki Sato, Yoshihiro Kitahara, Yayoi Yoshinaga, Kanon Abe, Chhoung Chanroth, Akuffo Golda Ataa, Zayar Phyo, Akemi Kurisu, Ko Ko, Tomoyuki Akita, Eisaku Kishita, Masao Kuwabara, Junko Tanaka
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract More than 200 million COVID-19 survivors have lasting symptoms after recovering, but the duration and related risk factors remain uncertain. This study focused on all 6551 patients diagnosed with COVID-19 at a medical institution in Hiroshim
Externí odkaz:
https://doaj.org/article/d0e0c5c32d064f04bbdb3a9d6b931ada
Autor:
Lola Mamazairovna Hujamberdieva, Odgerel Chimed-Ochir, Yui Yumiya, Junko Tanaka, Hiroki Ohge, Masao Kuwabara, Eisaku Kishita, Tatsuhiko Kubo
Publikováno v:
International Journal of Infectious Diseases, Vol 136, Iss , Pp 92-99 (2023)
Objectives: The present study investigates the diagnosis and prediction of COVID-19 based on clinical symptoms, and corresponding difference between the Delta- and Omicron-dominant periods, using data collected at polymerase chain reaction (PCR) cent
Externí odkaz:
https://doaj.org/article/b4a2596a43ac45448e529d2fd50eee4f
Autor:
Shinya Ishii, Aya Sugiyama, Noriaki Ito, Kei Miwata, Yoshihiro Kitahara, Mafumi Okimoto, Akemi Kurisu, Kanon Abe, Hirohito Imada, Tomoyuki Akita, Tatsuhiko Kubo, Akira Nagasawa, Toshio Nakanishi, Toshiro Takafuta, Masao Kuwabara, Junko Tanaka
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Perceived discrimination and work impairment are commonly observed in COVID-19 survivors, but their relationship has not been well understood. We aimed to evaluate the role of discrimination in the development of psychological distress and w
Externí odkaz:
https://doaj.org/article/4ab1d49a47f54c96810ced5ac7353d33
Autor:
Ko Ko, Kazuaki Takahashi, Shintaro Nagashima, Bunthen E, Serge Ouoba, Md Razeen Ashraf Hussain, Tomoyuki Akita, Aya Sugiyama, Takemasa Sakaguchi, Hidetoshi Tahara, Hiroki Ohge, Hideki Ohdan, Tatsuhiko Kubo, Nobuhisa Ishikawa, Toshiro Takafuta, Yoshiki Fujii, Michi Mimori, Fumie Okada, Eisaku Kishita, Kunie Ariyoshi, Masao Kuwabara, Junko Tanaka
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract This study aimed to develop the feasible and effective universal screening strategy of the notable SARS-CoV-2 variants by Sanger Sequencing Strategy and then practically applied it for mass screening in Hiroshima, Japan. A total of 734 sampl
Externí odkaz:
https://doaj.org/article/0f1cf7d725a644ee91f89367d8d92ee2
Autor:
Ko Ko, Shintaro Nagashima, Bunthen E, Serge Ouoba, Tomoyuki Akita, Aya Sugiyama, Masayuki Ohisa, Takemasa Sakaguchi, Hidetoshi Tahara, Hiroki Ohge, Hideki Ohdan, Tatsuhiko Kubo, Eisaku Kishita, Masao Kuwabara, Kazuaki Takahashi, Junko Tanaka
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246383 (2021)
BackgroundIn this study, we performed molecular characterization of SARS-CoV-2 strains in Hiroshima and its mutation pattern between the first and second waves of the outbreak.MethodA total of 55 nasal swab samples from the first wave in Hiroshima an
Externí odkaz:
https://doaj.org/article/496e4a97030549729f51a488cda73c7b
Autor:
Ko Ko, Kazuaki Takahashi, Shintaro Nagashima, Bunthen E, Serge Ouoba, Toshiro Takafuta, Yoshiki Fujii, Michi Mimori, Fumie Okada, Eisaku Kishita, Kunie Ariyoshi, Md Razeen Ashraf Hussain, Aya Sugiyama, Tomoyuki Akita, Masao Kuwabara, Junko Tanaka
Publikováno v:
Viruses, Vol 14, Iss 4, p 720 (2022)
This study aimed to exercise the Sanger sequencing strategy for screening of variants among confirmed COVID-19 cases and validate our strategy against NGS strains in Hiroshima retrieved from GISAID. A total of 660 samples from confirmed COVID-19 case
Externí odkaz:
https://doaj.org/article/dc33e8f5258343d69741bb2125e02278
Autor:
Mutsuko Utagawa, Hideko Sugiura, Kazuhisa Mezaki, Yoshimi Sato, Hideki Ikeda, Makoto Miki, Sayoko Kawakami, Kazufumi Hiramatsu, Junko Sato, Masao Tateyama, Yoshinobu Ohsaki, Hirokazu Tokuyasu, Satoru Fujiuchi, Mitsuo Kaku, Eriko Morino, Satoshi Iwata, Hiroshi Kiyota, Tomotaro Wakamura, Akira Watanabe, Eiichirou Mihara, Yasuo Honma, Kenichi Takeuchi, Yasuhiro Katono, Takeshi Saraya, Mikio Yamashita, Noriko Mitsuno, Jun-ichi Kadota, Yasunori Fujikawa, Satoshi Hino, Kiyoshi Negayama, Toshiyuki Ota, Masao Doi, Koji Ui, Akihiro Nakamura, Junichi Honda, Jiro Fujita, Nobuki Aoki, Futoshi Higa, Yasunao Wada, Katsunori Yanagihara, Hideaki Hanaki, Nobuchika Kusano, Yoshio Takesue, Takayuki Miyara, Masao Kuwabara, Keisuke Sunakawa, Makoto Kudo, Takahiro Takuma, Jin Takasaki, Hiroki Magarifuchi, Hajime Goto, Daisuke Kurai, Keiichi Mikasa, Minoru Ohashi, Manabu Takahashi, Mami Fukuoka, Hajime Nishiya, Atsushi Nakamura, Masaki Yoshida, Takahito Nakamura, Rika Inose, Yaeko Watanabe, Masaki Fujita, Yuka Yamagishi, Tetsuya Matsumoto, Nobuei Watabe, Masafumi Seki, Hiroshige Mikamo, Naohiko Chonabayashi, Yosuke Aoki, Motoko Nose, Yoshihito Niki, Norihito Kaku, Hiroshi Takahashi, Zenzo Nagasawa, Hiroki Tsukada, Akira Ukimura, Masahiro Toyokawa, Hiroaki Takeda, Toshinori Kawanami, Kei Kasahara, Chie Tanaka, Keisuke Sugimoto, Hiroshi Mukae, Susumu Nakanowatari, Mika Morimura, Shigeru Ehara, Shigeto Hamaguchi, Saori Fukuda
Publikováno v:
Journal of Infection and Chemotherapy. 23:587-597
The nationwide surveillance on antimicrobial susceptibility of bacterial respiratory pathogens from the patients in Japan was conducted by Japanese Society of Chemotherapy, Japanese association for infectious diseases and Japanese society for Clinica
Autor:
Aya Sugiyama, Eisaku Kishita, Shintaro Nagashima, Tatsuhiko Kubo, Kazuaki Takahashi, Takemasa Sakaguchi, Ko Ko, Hideki Ohdan, Hidetoshi Tahara, Masao Kuwabara, Bunthen E, Hiroki Ohge, Serge Ouoba, Masayuki Ohisa, Junko Tanaka, Tomoyuki Akita
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246383 (2021)
PLoS ONE
PLoS ONE
Background In this study, we performed molecular characterization of SARS-CoV-2 strains in Hiroshima and its mutation pattern between the first and second waves of the outbreak. Method A total of 55 nasal swab samples from the first wave in Hiroshima
Autor:
Kenichi Takeuchi, Nobuyuki Kobayashi, Yasunori Fujikawa, Hajime Goto, Michi Shoji, Daisuke Kurai, Nobuchika Kusano, Nobuki Aoki, Masahiro Toyokawa, Katsunori Yanagihara, Kazufumi Hiramatsu, Junko Sato, Hiroyuki Muranaka, Yuji Kawasaki, Hiroaki Takeda, Yumiko Imai, Satoshi Kawasaki, Yoshitomo Morinaga, Keisuke Sunakawa, Takayuki Miyara, Junichi Honda, Kayoko Masui, Makoto Miki, Kei Kasahara, Kaori Sato, Sayoko Kawakami, Masahiko Nakamura, Seishi Asari, Tadahiro Nakamura, Zenzo Nagasawa, Kazuhisa Mezaki, Toshinobu Yamamoto, Tetsuya Matsumoto, Nobuyoshi Ban, Toyoko Oguri, Hisami Konosaki, Yoshimi Sato, Satoshi Iwata, Reiko Sano, Mitsuo Kaku, Noriko Mitsuno, Jin Takasaki, Yuji Fujikura, Masao Kuwabara, Masaki Fujita, Eri Toyoshima, Moritaka Suga, Keiichi Mikasa, Hiroki Tsukada, Tomotaro Wakamura, Isao Nishi, Morimasa Yagisawa, Naoki Miyazawa, Kiyoshi Negayama, Mitsuhiro Okazaki, Mutsuko Utagawa, Ayami Tsukada, Takashi Yoshida, Hideaki Hanaki, Haruki Sawamura, Mayumi Shiokoshi, Susumu Nakanowatari, Hirofumi Toda, Hiroki Magarifuchi, Akihiko Kawana, Keisuke Sugimoto, Katsu Saionji, Yasuo Honma, Hiroshi Takahashi, Takeshi Saraya, Yoshinobu Ohsaki, Kazuhiko Ogasawara, Yumiko Yamamoto, Makoto Kudo, Hajime Nishiya, Koichiro Yoshida, Eiichirou Mihara, Tomohisa Watari, Yasuko Aoki, Akira Watanabe, Kenichi Takeda, Masaki Yoshida, Yutaka Koguchi, Mami Fukuoka, Yoshihito Niki, Masaki Yamamoto, Yaeko Watanabe, Hiroshige Mikamo, Hirokazu Tokuyasu, Yosuke Aoki, Jun-ichi Kadota, Toshio Kumagai, Naoyuki Miyashita
Publikováno v:
Journal of Infection and Chemotherapy. 21(6):410-420
The nationwide surveillance on antimicrobial susceptibility of bacterial respiratory pathogens from patients in Japan, was conducted by Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases and Japanese Society for Clinical M
Autor:
Yumi Yamada, Masakazu Kamituna, Masao Doi, Masao Kuwabara, Yaeko Watanabe, Kumi Ooshita, Yoshihiro Fujiue, Satomi Shimizu
Publikováno v:
Kansenshogaku Zasshi. 88:160-165
Mycoplasma pneumoniae is one of the common pathogens of the community-acquired pneumonia in adults and children. Macrolide antibiotics are considered to be the first-choice drug for M. pneumoniae infections. However, macrolide-resistant M. pneumoniae